The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Open accessAbstract
Summary Translocations involving the Mixed Lineage Leukemia (MLL) gene result in human acute leukemias with very poor prognosis. The leukemogenic activity of MLL fusion proteins is critically dependent on their direct interaction with menin, a product of the MEN1 gene. Here, we present the first small molecule inhibitors of the menin-MLL fusion protein interaction that specifically bind to menin with nanomolar affinities. These compounds effectively reverse MLL fusion protein-mediated leukemic transformation by downregulating the expression of target genes required for MLL fusion protein oncogenic activity. They also selectively block proliferation and induce both apoptosis and differentiation of leukemia cells harboring MLL translocations. Identification of these compounds provides a new tool for better understanding MLL-mediated leukemogenesis and represents a new approach for studying the role of menin as an oncogenic cofactor of MLL fusion proteins. Our findings also highlight a new therapeutic strategy for aggressive leukemias with MLL rearrangements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Mayer, M., & Meyer, B. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0100120 · Cited by 1,200
Yokoyama, A., Somervaille, T. C. P., Smith, K. S., Rozenblatt-Rosen, O., Meyerson, M., & Cleary, M. L. (2005) · Cell · doi:10.1016/j.cell.2005.09.025 · Cited by 688
Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D. J., Kitabayashi, I., Herr, W., & Cleary, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5639-5649.2004 · Cited by 662
Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus
Hughes, C. M., Rozenblatt-Rosen, O., Milne, T. A., Copeland, T. D., Levine, S. S., Lee, J. C., Hayes, D. N., Shanmugam, K. S., Bhattacharjee, A., Biondi, C. A., et al. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00081-4 · Cited by 645
Self-citationHox genes in hematopoiesis and leukemogenesis
Argiropoulos, B., & Humphries, R. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210760 · Cited by 492
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
Milne, T. A., Hughes, C. M., Lloyd, R., Yang, Z., Rozenblatt-Rosen, O., Dou, Y., Schnepp, R. W., Krankel, C., LiVolsi, V. A., Gibbs, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408836102 · Cited by 469
Self-citationTransformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
Ayton, P. M., & Cleary, M. L. (2003) · Genes & Development · doi:10.1101/gad.1111603 · Cited by 436
Lavau, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4226 · Cited by 400
Pui, C.-H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A., Kamps, W., Silverman, L. B., Biondi, A., Harms, D. O., Vilmer, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08782-2 · Cited by 399
Yokoyama, A., Lin, M., Naresh, A., Kitabayashi, I., & Cleary, M. L. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.040 · Cited by 374
MLL: a histone methyltransferase disrupted in leukemia
Hess, J. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.005 · Cited by 360
Self-citationHoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization
Zeisig, B. B., Milne, T., García-Cuéllar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.617-628.2004 · Cited by 328
Self-citationMolecular genetics of multiple endocrine neoplasia types 1 and 2
Marx, S. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1610 · Cited by 322
The molecular biology of mixed lineage leukemia
Slany, R. K. (2009) · Haematologica · doi:10.3324/haematol.2008.002436 · Cited by 321
Lawrence, H. J., Helgason, C. D., Sauvageau, G., Fong, S., Izon, D. J., Humphries, R. K., & Largman, C. (1997) · Blood · doi:10.1182/blood.v89.6.1922 · Cited by 304
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
Wong, P., Iwasaki, M., Somervaille, T. C. P., So, C. W. E., & Cleary, M. L. (2007) · Genes & Development · doi:10.1101/gad.1602107 · Cited by 266
Defects in Yolk Sac Hematopoiesis in Mll-Null Embryos
Hess, J. L., Yu, B. D., Li, B., Hanson, R., & Korsmeyer, S. J. (1997) · Blood · doi:10.1182/blood.v90.5.1799 · Cited by 257
Self-citationMLL-AF9-Induced Leukemogenesis Requires Coexpression of the Wild-Type Mll Allele
Thiel, A. T., Blessington, P., Zou, T., Feather, D., Wu, X., Yan, J., Zhang, H., Liu, Z., Ernst, P., Koretzky, G. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.034 · Cited by 248
The PAF Complex Synergizes with MLL Fusion Proteins at HOX Loci to Promote Leukemogenesis
Muntean, A. G., Tan, J., Sitwala, K., Huang, Y., Bronstein, J., Connelly, J. A., Basrur, V., Elenitoba-Johnson, K. S. J., & Hess, J. L. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.012 · Cited by 231
Self-citationMLL associates specifically with a subset of transcriptionally active target genes
Milne, T. A., Dou, Y., Martin, M. E., Brock, H. W., Roeder, R. G., & Hess, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503630102 · Cited by 230
Self-citationInteraction of MLL Amino Terminal Sequences with Menin Is Required for Transformation
Caslini, C., Yang, Z., El-Osta, M., Milne, T. A., Slany, R. K., & Hess, J. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2369 · Cited by 214
Self-citationQuantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia
Drabkin, H., Parsy, C., Ferguson, K., Guilhot, F., Lacotte, L., Roy, L., Zeng, C., Baron, A., Hunger, S., Varella-Garcia, M., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402354 · Cited by 185
Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality
Rozovskaia, T., Feinstein, E., Mor, O., Foa, R., Blechman, J., Nakamura, T., Croce, C. M., Cimino, G., & Canaani, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204174 · Cited by 181
Chen, Y.-X., Yan, J., Keeshan, K., Tubbs, A. T., Wang, H., Silva, A., Brown, E. J., Hess, J. L., Pear, W. S., & Hua, X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510347103 · Cited by 175
Self-citationSorensen, P. H., Chen, C. S., Smith, F. O., Arthur, D. C., Domer, P. H., Bernstein, I. D., Korsmeyer, S. J., Hammond, G. D., & Kersey, J. H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116978 · Cited by 161
The role of MLL in hematopoiesis and leukemia
Ernst, P., Wang, J., & Korsmeyer, S. J. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00004 · Cited by 157
Fiskus, W. C., Pranpat, M., Balasis, M. E., Herger, B. E., Rao, R., Chinnaiyan, A. M., Atadja, P. W., & Bhalla, K. N. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0418 · Cited by 125
MLL fusions: Pathways to leukemia
Liu, H., Cheng, E. H., & Hsieh, J. J. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.13.8924 · Cited by 116
Crystal Structure of Menin Reveals Binding Site for Mixed Lineage Leukemia (MLL) Protein
Murai, M. J., Chruszcz, M., Reddy, G., Grembecka, J. E., & Cierpicki, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.258186 · Cited by 110
Self-citationMolecular Basis of the Mixed Lineage Leukemia-Menin Interaction
Grembecka, J. E., Belcher, A. M., Hartley, T., & Cierpicki, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172783 · Cited by 99
Self-citationWhen epigenetics kills: MLL fusion proteins in leukemia
Slany, R. K. (2005) · Hematological Oncology · doi:10.1002/hon.739 · Cited by 95
Popovic, R., & Zeleznik‐Le, N. J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20430 · Cited by 94
Thomas, M., Geßner, A., Vornlocher, H., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1283 · Cited by 91
HOX deregulation in acute myeloid leukemia
Rice, K. L., & Licht, J. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31861 · Cited by 76
Thompson, A., Quinn, M. F., Grimwade, D. J., O'Neill, C. M., Ahmed, M., Grimes, S., McMullin, M. F., Cotter, F. E., & Lappin, T. R. J. (2003) · Blood · doi:10.1182/blood.v101.4.1558 · Cited by 76
Expression ofHOXGenes in Acute Leukemia Cell Lines with and withoutMLLTranslocations
Quentmeier, H., Dirks, W. G., MacLeod, R. A. F., Reinhardt, J., Zaborski, M., & Drexler, H. G. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001609942 · Cited by 59
Cox, M. C., Panetta, P., Lo‐Coco, F., Poeta, G. D., Venditti, A., Maurillo, L., Principe, M. I. D., Mauriello, A., Anemona, L., Bruno, A., et al. (2004) · American Journal of Clinical Pathology · doi:10.1309/rx27-r8gj-qm33-0c22 · Cited by 53
Chromosomal Aberration of the 11q23 Locus in Acute Leukemia and Frequency ofMLLGene Translocation
Cox, M. C., Panetta, P., Lo‐Coco, F., Poeta, G. D., Venditti, A., Maurillo, L., Principe, M. I. D., Mauriello, A., Anemona, L., Bruno, A., et al. (2004) · American Journal of Clinical Pathology · doi:10.1309/rx27r8gjqm330c22 · Cited by 50
Cited by
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Targeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rao, R. C., & Dou, Y. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3929 · Cited by 669
Metadata
- Authors
- Grembecka, J., He, S., Shi, A., Purohit, T., Muntean, A. G., Sorenson, R. J., Showalter, H. D., Murai, M. J., Belcher, A. M., Hartley, T., Hess, J. L., & Cierpicki, T.
- Venue
- Nature Chemical Biology
- Published
- 2012-01-29
- Volume
- 8
- Issue
- 3
- Pages
- 277-284
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W1990739246
- Cited by
- 462
- References
- 43
- FWCI
- 21.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.